Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Bosch

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Current Hematology Reports|July 13, 2005
Improving treatment approach in patients with chronic lymphocytic leukemiaFrancesc Bosch
Reviews in Clinical and Experimental Hematology|June 26, 2003
Refining prognostic factors in chronic lymphocytic leukemiaFrancesc Bosch, Emili Montserrat
Blood|November 7, 2015
Ibrutinib in CLL: 2 sides of the same coinFrancesc Bosch, Pau Abrisqueta
Blood|March 13, 2020
Venetoclax-obinutuzumab: harnessing complexityPau Abrisqueta, Francesc Bosch
Blood|April 14, 2018
Venetoclax after idelalisib: relevant progress for CLLFrancesc Bosch, Michael Hallek
Haematologica|July 15, 2003
ZAP-70 expression in CLL: a new parameter for an old diseaseFrancesc Bosch, Neus Villamor
Nature Reviews. Clinical Oncology|July 7, 2019
Chronic lymphocytic leukaemia: from genetics to treatmentFrancesc Bosch, Riccardo Dalla-Favera
Cancer Journal (Sudbury, Mass.)|August 16, 2021
Genetics of Chronic Lymphocytic LeukemiaFrancesc Bosch, Riccardo Dalla-Favera
Expert Review of Hematology|February 17, 2011
Personalizing treatment for chronic lymphocytic leukemiaPau Abrisqueta, Marta Crespo, Francesc Bosch
Annals of Hematology|August 11, 2021
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysisGuillermo Villacampa, Rodrigo Dienstmann, Francesc Bosch, et al.
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Current Hematology Reports|July 13, 2005
Improving treatment approach in patients with chronic lymphocytic leukemiaFrancesc Bosch
Reviews in Clinical and Experimental Hematology|June 26, 2003
Refining prognostic factors in chronic lymphocytic leukemiaFrancesc Bosch, Emili Montserrat
Blood|November 7, 2015
Ibrutinib in CLL: 2 sides of the same coinFrancesc Bosch, Pau Abrisqueta
Blood|March 13, 2020
Venetoclax-obinutuzumab: harnessing complexityPau Abrisqueta, Francesc Bosch
Blood|April 14, 2018
Venetoclax after idelalisib: relevant progress for CLLFrancesc Bosch, Michael Hallek
Haematologica|July 15, 2003
ZAP-70 expression in CLL: a new parameter for an old diseaseFrancesc Bosch, Neus Villamor
Nature Reviews. Clinical Oncology|July 7, 2019
Chronic lymphocytic leukaemia: from genetics to treatmentFrancesc Bosch, Riccardo Dalla-Favera
Cancer Journal (Sudbury, Mass.)|August 16, 2021
Genetics of Chronic Lymphocytic LeukemiaFrancesc Bosch, Riccardo Dalla-Favera
Expert Review of Hematology|February 17, 2011
Personalizing treatment for chronic lymphocytic leukemiaPau Abrisqueta, Marta Crespo, Francesc Bosch
Annals of Hematology|August 11, 2021
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysisGuillermo Villacampa, Rodrigo Dienstmann, Francesc Bosch, et al.
Pageof 17